ATH — Alterity Therapeutics Share News
0.000.00%
- AU$1.96m
- -AU$47.14m
- AU$0.45m
Australia Stock Exchange release from ALTERITY THERAPE : Change in substantial holding
Australia Stock Exchange release from ALTERITY THERAPE : Notification of cessation of securities - ATH
Australia's Alterity Therapeutics soars on trial nod for Parkinson's drug
Australia Stock Exchange release from ALTERITY THERAPE : PRE_NR Ends: 09:52:48
Australia Stock Exchange release from ALTERITY THERAPE : First Regulatory Authorization to Proceed with Phase 2 Trial
Australia Stock Exchange release from ALTERITY THERAPE : Notification regarding unquoted securities - ATH
Australia Stock Exchange release from ALTERITY THERAPE : Change in substantial holding
Australia Stock Exchange release from ALTERITY THERAPE : Change in substantial holding
Australia Stock Exchange release from ALTERITY THERAPE : Alterity to present at upcoming investor conferences
Australia Stock Exchange release from ALTERITY THERAPE : Results of Annual General Meeting
Australia Stock Exchange release from ALTERITY THERAPE : PRE_NR Ends: 09:04:31
Australia Stock Exchange release from ALTERITY THERAPE : ATH Annual General Meeting Presentation
Australia Stock Exchange release from ALTERITY THERAPE : PRE_NR Ends: 09:01:11
Australia Stock Exchange release from ALTERITY THERAPE : Chairman's Address 2021 Annual General Meeting
Australia Stock Exchange release from ALTERITY THERAPE : Alterity presents at American Autonomic Society Meeting
Australia Stock Exchange release from ALTERITY THERAPE : New Data Advance ATH434 as Neurodegeneration treatment
Australia Stock Exchange release from ALTERITY THERAPE : PRE_NR Ends: 13:34:49
Australia Stock Exchange release from ALTERITY THERAPE : Change in substantial holding
Australia Stock Exchange release from ALTERITY THERAPE : PRE_NR Ends: 11:02:25